• Privacy Debates Over HeLa Cell Sequence

    ScienceInsider | A debate has been raging over the ethics of sequencing the HeLa cell line without the consent of Henrietta Lacks' family, and many in the community have weighed in.

    Mar 26, 2013

  • Nimbus Releases New Flash Storage Software

    SemiAccurate | Nimbus Data released a software suite--Halo 2013--for their flash storage offerings. The software is a free update for existing customers and brings an analysis system, API, and mobile monitoring suite.

    Mar 26, 2013

  • Systems Biology Initiative Plans Computer-Simulated Skin Model

    News Brief | Bio-Modeling Systems (BMSystems) of France and Persistent Systems of India are launching a joint systems biology research and development initiative that will marry non-mathematical heuristic modeling with mathematical modeling designed to increase the success rates of drug discovery and formulation development.

    Mar 25, 2013

  • 2012 Growth Year for HPC Market

    eWeek | 2012 saw record revenues in the high-performance computer market, led by IBM and HP. Supercomputers led the growth, with a 29.3% increase in revenues.

    Mar 25, 2013

  • History of OpenStack and NASA

    ComputerWorld | The OpenStack cloud platform got IBM's vote of approval earlier this month. The technology was originally tied to NASA's Nebula project a 2008.

    Mar 25, 2013

  • IBM's Ion Current Chips

    eWeek | IBM’s scientists discovered a new way to operate chips using tiny ionic currents, which are streams of charged atoms that could mimic the event-driven way in which the human brain operates.

    Mar 22, 2013

  • Bibliogo is RSS Reader for Life Sciences

    Bio-IT World Product Brief | Looking for a Google Reader replacement? Bibliogo is an RSS reader designed specifically for science, says Reprints Desk.

    Mar 22, 2013

  • AMCG Releases Recommendations for Dealing with Sequencing Findings

    Nature | The American College of Medical Genetics and Genomics yesterday released recommendations for how genome-sequencing laboratories should report incidental findings after a doctor orders a genome sequence. It defines a minimum list of about 60 genes and 30 conditions that should be reported to the doctor as part of a patient’s care, whether the patient wants to know them or not.

    Mar 22, 2013

  • UK Biobank and Affymetrix Sign 500,000-Sample Genotyping Agreement

    Bio-IT World | UK Biobank and Affymetrix have signed a contract to genotype 500,000 DNA samples donated by UK residents as part of a prospective epidemiological study of complex diseases that are of great relevance to public health using Affymetrix’ Axiom Genotyping Solution.

    Mar 22, 2013

  • Ra Pharmaceuticals and the Pursuit of Peptide Drugs

    Bio-IT World Video | Doug Treco, president & CEO of Ra Pharmaceuticals, will be presenting at CHI’s Drug Discovery Chemistry conference in San Diego in April. He gives Bio-IT World editor Kevin Davies some insight into the world of cyclomimetics.

    Mar 22, 2013

  • AstraZeneca Cuts More Jobs; Signs $240M+ Agreement with Moderna

    Bio-IT World Roundup | Lots of news for AstraZeneca this morning. The company announced plans to cut 2300 sales and administrative jobs and plans to focus on respiratory, inflammation & autoimmunity; cardiovascular & metabolic disease; and oncology. The company also announced a major agreement with Moderna Therapeutics, starting with a $240 million upfront payment for mRNA research.

    Mar 21, 2013

  • March Product and News Briefs

    Bio-IT World | News briefs for March including updates from Ingenuity, GeneInsight, University of Auckland, and the Research Resonance Network. New products from SoftGenetics, Accelrys, Cynvenio Biosystems, SGI, PerkinElmer and more.

    Mar 21, 2013

  • Big Data Freeway in San Diego

    New York Times | Larry Smarr and his team at UC  San Diego are about to open the “Big Data freeway system” for next-gen data projects including genomic sequencing. The new network--Prism--is based on an optical switch developed by Arista Networks.

    Mar 20, 2013

  • Following the Gleevec Blueprint

    Xconomy | Blueprint Medicines has reunited the team behind Gleevec—Nick Lydon, Brian Druker, and Charles Sawyers. The startup, backed with a $40 million Series A financing from Third Rock Ventures and Fidelity Biosciences in 2011, believes now is the time for more drugs like the cancer blockbuster.

    Mar 20, 2013

  • A Look at Gene Patents and Myriad

    PBS | On April 15, the Supreme Court will again hear a case against Myriad Genetics' gene patents. Though the legal debate is unlikely to end there, the decision could have implications for personalized medicine. Even the researcher who was originally responsible for the Myriad patent of BRCA2 has changed his tune.“

    Mar 20, 2013

  • DNA Editing Protein

    Forbes | They were trying to find a better way to make yogurt, but instead, they stumbled across a bacterial immune system and a protein that finds very specific DNA sequences. George Church's lab proved that the protein could make multiple, specific edits to a cell's DNA at once. From here, the possibilities are endless.

    Mar 19, 2013

  • Complete Genomics Acquisition Final

    Bio-IT World News Brief | BGI-Shenzhen has completed its acquisition of Complete Genomics through its wholly-owned subsidiary, Beta Acquisition Corporation.

    Mar 19, 2013

  • FindZebra: A Search Engine for Rare Disease

    Technology Review | FindZebra bests Google at the rare disease hunt. The new search engine is dedicated to identifying rare diseases using an index of databases including the Online Mendelian Inheritance in Man database and more.

    Mar 18, 2013

  • Bits and SNPs: Atul Butte and Medicine in the Era of Big Data

    Bio-IT World | One of the most surprising parts of Atul Butte’s lab website is his open-access calendar. At the bottom of his profile page, Butte, Chief of the Division of Systems Medicine at Stanford University and a keynote speaker for the Bio-IT World Expo on April 10, lists his daily commitments, instructions for making an appointment, and his assistant’s phone number. The message is subtle, but clear: personal data cannot stay personal for long if Big Data will succeed in medicine.

    Mar 18, 2013

  • Cuts and Reorgs at AstraZeneca

    Bloomberg | AstraZeneca announced that it will cut 1,600 jobs in an overhaul of the company's research and development efforts. The cuts will hopefully save the company $1.4 billion.

    Mar 18, 2013